---
title: "BETTA PHARMACEUTICALS released its performance for the first half of the year, with a net profit attributable to the parent company of 140 million yuan, a decrease of 37.53%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253616661.md"
description: "According to the Zhitong Finance APP, BETTA PHARMACEUTICALS released its semi-annual report for 2025, showing an operating income of 1.731 billion yuan, a year-on-year increase of 15.37%. The net profit attributable to shareholders of the listed company was 140 million yuan, a year-on-year decrease of 37.53%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 191 million yuan, a year-on-year decrease of 11.97%. The basic earnings per share were 0.33 yuan"
datetime: "2025-08-19T10:59:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253616661.md)
  - [en](https://longbridge.com/en/news/253616661.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253616661.md)
generator: "portal-rs"
---

# BETTA PHARMACEUTICALS released its performance for the first half of the year, with a net profit attributable to the parent company of 140 million yuan, a decrease of 37.53%

According to the Zhitong Finance APP, BETTA PHARMACEUTICALS (300558.SZ) released its semi-annual report for 2025, with operating revenue of 1.731 billion yuan, a year-on-year increase of 15.37%. The net profit attributable to shareholders of the listed company was 140 million yuan, a year-on-year decrease of 37.53%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 191 million yuan, a year-on-year decrease of 11.97%. The basic earnings per share were 0.33 yuan

### Related Stocks

- [0BDYY.HK](https://longbridge.com/en/quote/0BDYY.HK.md)
- [300558.CN](https://longbridge.com/en/quote/300558.CN.md)

## Related News & Research

- [5 things to know about the Chinese e-commerce juggernaut Shein ahead of its IPO](https://longbridge.com/en/news/296771842.md)
- [Bessent's bond gambit aimed at calming markets is instead stirring inflation worries](https://longbridge.com/en/news/296642975.md)
- [Trump’s Bond Buyback Push Puts Kevin Warsh in a Tough Spot — Peter Schiff Says Treasury ‘Pulled the Rug Out From Under’](https://longbridge.com/en/news/296615127.md)
- [Scott Bessent Brings His Hedge Fund Playbook To Treasury. The Bond Market Is Fighting Back](https://longbridge.com/en/news/296520391.md)
- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**